Boshi Fan
Beijing, 100048, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Journal: Pathology, research and practice
Published: October 30, 2023
FAM107A as a tumor suppressor in esophageal squamous carcinoma inhibits growth and metastasis.
Journal: Pathology, research and practice
Published: October 24, 2023
JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma.
Journal: The journal of gene medicine
Published: October 06, 2023
Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2023
ASO Author Reflections: 3-Year Survival Outcomes of Lymphadenectomy in Minimally Invasive Esophagectomy.
Journal: Annals of surgical oncology
Published: June 13, 2023
Three-Field Versus Two-Field Lymphadenectomy in Minimally Invasive Esophagectomy: 3-Year Survival Outcomes of a Randomized Trial.
Journal: Annals of surgical oncology
Published: March 19, 2023
Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series.
Journal: Thoracic cancer
Published: January 14, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026